Junction vs Idexx Laboratories

Side-by-side comparison of AI visibility scores, market position, and capabilities

Idexx Laboratories leads in AI visibility (94 vs 35)
Junction logo

Junction

EmergingHealthcare

General

US YC health data API infrastructure connecting 500+ wearables and at-home lab tests for 140+ healthcare orgs; $18M Creandum Series A Mar 2025 supporting 2M+ connected devices and 500K+ tests annually competing with Validic and Terra API.

AI VisibilityBeta
Overall Score
D35
Category Rank
#541 of 1158
AI Consensus
52%
Trend
up
Per Platform
ChatGPT
34
Perplexity
45
Gemini
28

About

Junction is a United States-based health data infrastructure company — backed by Y Combinator with $18 million in Series A funding in March 2025 led by Creandum with participation from Point Nine, Amino Collective, and Inflect Health — providing digital health companies, research organizations, and healthcare technology platforms with a unified API infrastructure for collecting wearable device data (500+ supported devices including Apple Watch, Fitbit, Oura, Garmin, and continuous glucose monitors) and delivering at-home diagnostic test kits to patients with automated diagnostic data workflows that connect labs, wearables, and health systems. Founded and serving 140+ healthcare organizations including Found, Parsley Health, and Evidation, Junction supports 500,000+ lab tests annually and 2 million+ connected devices.

Full profile
Idexx Laboratories logo

Idexx Laboratories

LeaderHealthcare Tech

Enterprise

Veterinary diagnostics leader with $3.81B FY2024 revenue; 130,000+ analyzer installed base; AI-powered inVue Dx digital cytology; VetConnect data platform; pet humanization tailwind.

AI VisibilityBeta
Overall Score
A94
Category Rank
#19 of 290
AI Consensus
71%
Trend
stable
Per Platform
ChatGPT
99
Perplexity
92
Gemini
88

About

IDEXX Laboratories is the global leader in veterinary diagnostics and information technology for companion animal healthcare, founded in 1983 by David Shaw in Westbrook, Maine, where it remains headquartered. The company trades on Nasdaq (IDXX) and reported $3.81 billion in revenues for FY2024, maintaining its dominant position in point-of-care veterinary diagnostics through an installed base of over 130,000 Catalyst chemistry analyzers, ProCyte hematology systems, and SNAP rapid assay devices deployed in veterinary clinics worldwide. CEO Jay Mazelsky has continued IDEXX's expansion into AI-powered diagnostics and digital pathology, building on over four decades of veterinary-specific product development.

Full profile

AI Visibility Head-to-Head

35
Overall Score
94
#541
Category Rank
#19
52
AI Consensus
71
up
Trend
stable
34
ChatGPT
99
45
Perplexity
92
28
Gemini
88
44
Claude
94
46
Grok
99

Key Details

Category
General
Enterprise
Tier
Emerging
Leader
Entity Type
brand
company

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.